FDA recall, , Moderate risk
Greenstone Methylprednisolone Tablets Dosepak
Methylprednisolone tablets have incorrect dosing information on the blister foil.
Summary by Recall Canary from the FDA notice
What happened
Greenstone LLC of Peapack, New Jersey, recalled methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, because incorrect orientation of the blister foil applied to the blister cavities results in incorrect dosing information when following the directions on the foil. The recall began January 15, 2026, and was added to the FDA's Enforcement Report on January 28, 2026.
The product was distributed nationwide within the United States. The recall involved 3456 cartons.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
methylprednisolone tablets, USP Dosepak, 4 mg
- NDC
- 59762-4440-2
- Lot code
- LG7675
Recall details
- Company began the recall
- Sold in
Nationwide within the United States
- Company
- Greenstone LlcPeapack, New Jersey
- Hazard
- Labeling error
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98278
- Recall number
- D-0299-2026
- Quantity recalled
- 3456 cartons
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
